US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6092-1 D-0724-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6078-1 D-0723-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6076-1 D-0722-2023
Class II · Moderate risk Terminated

vancomycin added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6075-1 D-0721-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6074-1 D-0720-2023
Class II · Moderate risk Terminated

vancomycin added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6073-1 D-0719-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6071-1 D-0718-2023
Class II · Moderate risk Terminated

vancomycin added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6064-1 D-0717-2023
Class II · Moderate risk Terminated

PHENYLephrine added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6058-1 D-0715-2023
Class II · Moderate risk Terminated

norepinephrine 4 mg added to dextrose 5% 250 mL*

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6056-1 D-0714-2023
Class II · Moderate risk Terminated

dilTIAZem added to 0.9% sodium chloride

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6055-1 D-0713-2023
Class II · Moderate risk Terminated

dilTIAZem added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6054-1 D-0712-2023
Class II · Moderate risk Terminated

oxyTOCIN 60 units added to 0.9% sodium chloride 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6045-1 D-0711-2023
Class II · Moderate risk Terminated

oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6044-1 D-0710-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to 0.9% sodium chloride 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6043-1 D-0709-2023
Class II · Moderate risk Terminated

oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6042-1 D-0708-2023
Class II · Moderate risk Terminated

oxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6039-1 D-0707-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to Lactated Ringer's 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6038-1 D-0706-2023
Class II · Moderate risk Terminated

oxyTOCIN 15 units added to Lactated Ringer's 250 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6037-1 D-0705-2023
Class II · Moderate risk Terminated

oxyTOCIN 10 units added to Lactated Ringer's 500 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6036-1 D-0704-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to dextrose 5%/Lactated Ringer's 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6031-1 D-0702-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6030-1 D-0701-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0432-1 D-0700-2023